Transmural Biotech developed quantusFLM, a non‐invasive, fast, and easy‐to‐use Fetal Lung Maturity test that provides an accurate result within three minutes. The pilot with Cloudnine tested quantusFLM in the clinical practice of three maternity hospitals, with pregnant women at risk of late pre-term birth, or scheduled for an early term birth, to determine Fetal Lung Maturity by using only an ultrasound image during quantusFLM analysis.
February 8, 2017 - August 8, 2017
Two Cloudnine hospitals in Bengaluru and one in Mumbai
The main goal of the pilot was to show Cloudnine specialists the potential benefits of quantusFLM by allowing them to use the device in specific clinical cases. This goal was successfully accomplished.
Fetal Medicine Specialists used quantusFLM during the pilot with a high efficiency in image acquisition.
The Fetal Medicine Specialists were seamlessly trained with a structured protocol, despite potential complications.
Use of QuantusFLM was four times higher than expected.
The majority of specialists were able to correctly use the tool in the vast majority of the cases.
Transmural Biotech and Cloudnine are in discussions about a longer-term partnership.
The TechEmerge pilot has allowed Transmural Biotech to understand a new and complex market in a more efficient way.